Jonathan R. Hiatt MD, FACS

• Robert and Kelly Day Professor of General Surgery
• Chief, Division of General
• Surgery
• Vice Chairman for Education, Department of Surgery, David Geffen School
• of Medicine at University of California Los Angeles, Los Angeles, California

Among well-chosen patients diabete et hypertension arterielle order losartan 50 mg without prescription, up to 70% remain seizure-free after extended follow-up diabetes type 1 also known as 50 mg losartan order. Deep brain or cortical stimulation for medically refractory focal-onset seizures may be of benefit in medically refractory patients diabetes mellitus zuckerkrankheit purchase losartan canada. Tonic-clonic status epilepticus-Poor adherence to the anticonvulsant drug regimen is the most common cause; however diabetic diet 1800 cal losartan 25 mg buy low price, any disorder that can cause a single seizure may be responsible diabetes symptoms mood swings losartan 25 mg purchase otc. The mortality rate may be as high as 20%, and among survivors the incidence of neurologic and cognitive sequelae is high. The prognosis relates to the underlying cause as well as the length of time between onset of status epilepticus and the start of effective treatment. Initial management includes maintenance of the airway and 50% dextrose (25­50 mL) intravenously in case hypoglycemia is responsible. If seizures continue, an intravenous bolus of lorazepam, 4 mg, is given at a rate of 2 mg/min and repeated once after 10 minutes if necessary; alternatively, 10 mg of midazolam is given intramuscularly, and again after 10 minutes if necessary. Respiratory depression and hypotension may complicate the treatment and are treated as in other circumstances, including intubation and mechanical ventilation and admission to an intensive care unit. Regardless of the response to lorazepam or midazolam, fosphenytoin or phenytoin should be administered intravenously to initiate long-term seizure control. When fosphenytoin is not available, phenytoin (18­20 mg/kg) is given intravenously at a rate of 50 mg/min. Phenytoin is best injected directly but can also be given in saline; it precipitates, however, if injected into glucose-containing solutions. Because arrhythmias may develop during rapid administration of fosphenytoin or phenytoin, electrocardiographic monitoring is prudent. If seizures continue, phenobarbital is then given in a loading dose of 10­20 mg/kg intravenously by slow or intermittent injection (50 mg/min). Intravenous midazolam may provide control of refractory status epilepticus; the suggested loading dose is 0. Vagal nerve stimulation-Treatment by chronic vagal nerve stimulation for adults and adolescents with medically refractory focal seizures is approved in the United States and provides an alternative approach for patients who are not optimal candidates for surgical treatment. Solitary seizures-In patients who have had only one seizure or a flurry of seizures over a brief period of several hours, investigation as outlined earlier should exclude an underlying cause requiring specific treatment. An electroencephalogram should be obtained, preferably within 24 hours after the seizure. Prophylactic anticonvulsant drug treatment is generally not required unless further attacks occur or investigations reveal underlying pathology. The risk of seizure recurrence varies in different series between about 30% and 70%, with higher risk of recurrence in patients with structural brain lesions or abnormalities on electroencephalogram. If seizures occur in the context of transient, nonrecurrent systemic disorders such as hyponatremia or hypoglycemia, the diagnosis of epilepsy is inaccurate, and long-term prophylactic anticonvulsant drug treatment is unnecessary. Alcohol withdrawal seizures-The characteristic alcohol withdrawal seizure pattern is one or more generalized tonic-clonic seizures that may occur within 48 hours or so of withdrawal from alcohol after a period of high or prolonged intake. If the seizures have consistently focal features, the possibility of an associated structural abnormality, often traumatic in origin, must be considered. Treatment with anticonvulsant drugs is generally not required for alcohol withdrawal seizures, since they are self-limited. After status epilepticus is controlled, an oral drug program for the long-term management of seizures is started, and investigations into the cause of the disorder are pursued. Nonconvulsive status epilepticus-In some cases, status epilepticus presents not with convulsions, but with a fluctuating abnormal mental status, confusion, impaired responsiveness, and automatism. The treatment approach outlined above applies to any type of status epilepticus, although intravenous anesthesia is usually not necessary. The prognosis is a reflection of the underlying cause rather than of continuing seizures. Syncope, a symptom of dysautonomia, is characterized by a transient loss of consciousness, usually accompanied by hypotension and bradycardia. It may occur in response to emotional stress, postural hypotension, vigorous exercise in a hot environment, obstructed venous return to the heart, acute pain or its anticipation, fluid loss, and a variety of other circumstances. Central Neurologic Causes s errs ook e ook b b · · · · » When to Refer Behavioral episodes of uncertain nature. Peripheral Neurologic Causes A pure autonomic neuropathy may occur acutely or subacutely after a viral infection or as a paraneoplastic disorder related usually to small cell lung cancer, particularly in association with certain antibodies, such as anti-Hu or those directed at neuronal nicotinic ganglionic acetylcholine receptors. Dysautonomia is often conspicuous in patients with Guillain-Barré syndrome, manifesting with marked hypotension or hypertension or cardiac arrhythmias that may have a fatal outcome. It may also occur with diabetic, uremic, amyloidotic, and various other metabolic or toxic neuropathies; in association with leprosy or Chagas disease; and as a feature of certain hereditary neuropathies with autosomal dominant or recessive inheritance or an X-linked pattern. Patients with botulism or the Lambert-Eaton myasthenic syndrome may have constipation, urinary retention, and a sicca syndrome as a result of impaired cholinergic function. Disease at certain sites in the central nervous system, regardless of its nature, may lead to dysautonomic symptoms. Postural hypotension, which is usually the most troublesome and disabling symptom, may result from spinal cord transection and other myelopathies (eg, due to tumor or syringomyelia) above the T6 level or from brainstem lesions such as syringobulbia and posterior fossa tumors. Certain primary degenerative disorders are responsible for dysautonomia occurring in isolation (pure autonomic failure) or in association with more widespread abnormalities (multisystem atrophy) that may include parkinsonism, pyramidal symptoms, and cerebellar deficits. Abnormalities of sweating, intestinal motility, sexual function, or sphincter control. It is manifested by a variety of symptoms related to abnormalities of blood pressure es kerrs oo k eb oo e//eb me Dysautonomic symptoms include syncope, postural hypotension, paroxysmal hypertension, persistent tachycardia without other cause, facial flushing, hypohidrosis or hyperhidrosis, vomiting, constipation, diarrhea, dysphagia, abdominal distention, disturbances of micturition or defecation, erectile dysfunction, apneic episodes, and declining night vision. Although the patient is usually flaccid, some motor activity is not uncommon, and urinary (and rarely fecal) incontinence may also occur, thereby simulating a seizure. Recovery is rapid once the patient becomes recumbent, but headache, nausea, and fatigue are common postictally. Pharmacologic studies to evaluate the pupillary responses, radiologic studies of the bladder or gastrointestinal tract, uroflowmetry and urethral pressure profiles, and recording of nocturnal penile tumescence may also be necessary in selected cases. Further investigation depends on the presence of other associated neurologic abnormalities. In patients with a peripheral cause, workup for peripheral neuropathy may be required and should include testing for ganglionic acetylcholine receptor antibody. For those with evidence of a central lesion, imaging studies will exclude a treatable structural cause. Postural hypotension and syncope may relate to a reduced cardiac output, paroxysmal cardiac dysrhythmias, volume depletion, various medications, and endocrine and metabolic disorders such as Addison disease, hypothyroidism or hyperthyroidism, pheochromocytoma, and carcinoid syndrome. Some patients will have a major stroke after only a few attacks, whereas others may have frequent attacks for weeks or months without having a stroke. The risk of stroke is high in the first 3 months after an attack, particularly in the first month and especially within the first 48 hours. In general, carotid ischemic attacks are more liable than vertebrobasilar ischemic attacks to be followed by stroke. Abrupt postural change, prolonged recumbency, and other precipitants should be avoided. Medications associated with postural hypotension should be discontinued or reduced in dose. Treatment may include wearing waist-high elastic hosiery, salt supplementation, sleeping in a semierect position (which minimizes the natriuresis and diuresis that occur during recumbency), and fludrocortisone (0. Other agents that have been used occasionally or experimentally are dihydroergotamine, yohimbine, pyridostigmine, and clonidine; refractory cases may respond to erythropoietin (epoetin alfa) or desmopressin. There is no satisfactory treatment for disturbances of sweating, but an airconditioned environment is helpful in avoiding extreme swings in body temperature. In many patients with these attacks, a source is readily apparent in the heart or a major extracranial artery to the head, and emboli sometimes are visible in the retinal arteries. An embolic phenomenon explains why separate attacks may affect different parts of the territory supplied by the same major vessel. Cardiac causes of embolic ischemic attacks include atrial fibrillation, heart failure, infective and nonbacterial thrombotic endocarditis, atrial myxoma, and mural thrombi complicating myocardial infarction. Atrial septal defects and patent foramen ovale may permit venous thromboemboli to reach the brain (paradoxical emboli). An ulcerated plaque on a major artery to the brain may serve as a source of emboli. In the anterior circulation, atherosclerotic changes occur most commonly in the region of the carotid bifurcation extracranially; these changes may cause a bruit. Severe anemia may also lead to transient focal neurologic deficits in patients with preexisting cerebral arterial disease. Symptoms develop when there is localized stenosis or occlusion of one subclavian artery proximal to the source of the vertebral artery, so that blood is "stolen" from the vertebral artery to supply the arm. Echocardiography with agitated saline contrast is performed if a cardioembolic source is likely, and blood cultures are obtained if endocarditis is suspected. Medical Measures Medical treatment is aimed at preventing further attacks and stroke. Treat diabetes mellitus; hematologic disorders; and hypertension, preferably with an angiotensinconverting enzyme inhibitor or angiotensin receptor blocker. Cigarette smoking should be stopped, and cardiac sources of embolization should be treated appropriately. Weight reduction and regular physical activity should be encouraged when appropriate. An antiplatelet or anticoagulant should be started as soon as imaging has established the absence of hemorrhage. Focal seizures usually cause abnormal motor or sensory phenomena such as clonic limb movements, paresthesias, or tingling, rather than weakness or loss of feeling. Symptoms generally spread ("march") up the limb and may lead to a generalized tonic-clonic seizure. Classic migraine is easily recognized by the visual premonitory symptoms, followed by nausea, headache, and photophobia, but less typical cases may be hard to distinguish. Patients with migraine are typically younger, commonly have a history of episodes since adolescence and report that other family members have a similar disorder. Focal neurologic deficits may occur during periods of hypoglycemia in diabetic patients receiving insulin or oral hypoglycemic agent therapy. Onset is abrupt and without warning, and recovery usually occurs rapidly, often within a few minutes. The specific symptoms depend on the arterial distribution affected, as outlined in the subsequent section on stroke. Hospitalization-Hospitalization should be considered for patients seen within a week of the attack, when they are at increased risk for early recurrence. Admission is also advisable for patients with crescendo attacks, symptomatic carotid stenosis, or a C. Patients with metal heart valves, left ventricular thrombus, and the antiphospholipid antibody syndrome should also receive anticoagulation therapy. For long-term anticoagulation in the setting of atrial fibrillation, dabigatran (150 mg orally twice daily), rivaroxaban (20 mg orally daily), and apixaban (2. Combination antiplatelet-anticoagulation therapy is only indicated in patients with mechanical heart valves or those with a separate indication for antiplatelet therapy such as a cardiac stent. A randomized trial of patients with heart failure (without atrial fibrillation) and an ejection fraction under 35% failed to show a benefit of warfarin over aspirin. Aspirin (81 mg daily orally), aspirin combined with extended-release dipyridamole (200 mg twice daily orally), or clopidogrel (75 mg daily orally) all have similar efficacy. Cilostazol (100 mg twice daily) had similar efficacy as aspirin at stroke prevention in an Asian population with less risk of hemorrhage. Combining clopidogrel with aspirin for the long term increases the risk of hemorrhagic complications and is not recommended. Diagnosis of atrial fibrillation after stroke and transient ischaemic attack: a systematic review and meta-analysis. Patient often has hypertension, diabetes mellitus, tobacco use, atrial fibrillation, or atherosclerosis. Endovascular therapy carries a slightly higher procedural stroke risk than endarterectomy in patients older than 70 years and is generally reserved for younger patients whose neck anatomy is unfavorable for surgery. Patients with symptomatic carotid stenosis of 50­69% derive moderate benefit from intervention, but surgery is not indicated for mild stenosis (less than 50%). Lacunar Infarction In the United States, stroke is the fifth leading cause of death and a leading cause of disability, despite a general decline in the incidence of stroke in the last 30 years. Antiplatelet; control risk factors (hypertension, tobacco use, hypercholesterolemia, and diabetes mellitus). Secondary prevention: antiplatelet agent is first-line therapy; anticoagulation without heparin bridge for cardioembolic strokes due to atrial fibrillation and other select cases when no contraindications exist; control risk factors as above. Commonly associated with hypertension; also with bleeding disorders, amyloid angiopathy. Hypertensive hemorrhage is located commonly in the basal ganglia, pons, thalamus, cerebellum, and less commonly the cerebral white matter. Lower systolic blood pressure to 140 mm Hg; cerebellar bleeds or hematomas with gross mass effect may require urgent surgical evacuation. Aneurysm: prevent further bleeding by clipping aneurysm or coil embolization; nimodipine helps prevent vasospasm; once aneurysm has been obliterated intravenous fluids and induced hypertension to prevent vasospasm; angioplasty may also reverse symptomatic vasospasm. The prognosis for recovery from the deficit produced by a lacunar infarct is usually good, with partial or complete resolution occurring over the following 4­6 weeks in many instances. Patients with a cilioretinal artery (approximately 25%) may have macular sparing due to collateral blood supply. Obstruction of vertebrobasilar circulation-Occlusion of the posterior cerebral artery may lead to a thalamic syndrome in which contralateral hemisensory disturbance occurs, followed by the development of spontaneous pain and hyperpathia.

Ciprofloxacin diabetes type 2 levels buy losartan 25 mg line, 500 mg orally every 12 hours for 5 days diabetes type 2 effects on body cheap losartan 50 mg on line, is effective in shortening the course of illness compared with placebo in patients presenting with diarrhea blood sugar variation discount losartan online visa, whether a pathogen is isolated or not diabetes diet type 2 purchase 25 mg losartan with amex. However diabetes test calgary buy losartan mastercard, because of concerns about selecting for resistant organisms (especially Campylobacter, where increasing resistance to fluoroquinolones has been documented and erythromycin is the drug of choice) coupled with the fact that most infectious diarrhea is self-limited, routine use of antibiotics for all patients with diarrhea is not recommended. Antibiotics should be considered in patients with evidence of invasive disease (white cells in stool, dysentery), with symptoms 3­4 days or more in duration, with multiple stools (eight to ten or more per day), and in those with impaired immune responses. Their use should be limited to patients without fever and without dysentery (bloody stools), and they should be used in low doses because of the risk of producing toxic megacolon. Postinfectious irritable bowel syndrome can follow infection and is approached in a similar fashion as in noninfectious irritable bowel syndrome. Therapeutic recommendations for specific agents can be found elsewhere in this book. Global prevalence of norovirus in cases of gastroenteritis: a systematic review and meta-analysis. World Health Organization estimates of the global and regional disease burden of 22 foodborne bacterial, protozoal, and viral diseases, 2010: a data synthesis. Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis. Outbreaks of acute gastroenteritis transmitted by person-to-person contact, environmental contamination, and unknown modes of transmission-United States, 2009­ 2013. General Measures In general, most cases of acute gastroenteritis are selflimited and do not require therapy other than supportive measures. Treatment usually consists of replacement of fluids and electrolytes and, very rarely, management of hypovolemic shock and respiratory compromise. In more severe cases of dehydration (postural light-headedness, decreased urination), oral glucose-based rehydration solutions can be used (Ceralyte, Pedialyte). Less than 3 weeks following exposure may suggest dengue, leptospirosis, and yellow fever; more than 3 weeks suggest typhoid fever, malaria, and tuberculosis. Meningoencephalitis Etiologies include N meningitidis, leptospirosis, arboviruses, rabies, and (cerebral) malaria. Jaundice Consider hepatitis A, yellow fever, hemorrhagic fever, leptospirosis, and malaria. The evaluation is best done by identifying whether a particular syndrome is present, then refining the differential diagnosis based on an exposure history. The travel history should include directed questions regarding geography (rural versus urban, specific country visited), time of year, animal or arthropod contact, unprotected sexual intercourse, ingestion of untreated water or raw foods, historical or pretravel immunizations, and adherence to malaria prophylaxis. Others include mononucleosis (associated with Epstein-Barr virus or cytomegalovirus), respiratory infections, including seasonal influenza, influenza A/H1N1 "swine" influenza, and influenza A/H5N1 or A/H7N9 "avian" influenza (see Chapter 32); leptospirosis (see Chapter 34); typhoid fever (see Chapter 33); and rickettsial infections (see Chapter 32). Systemic febrile illnesses without a diagnosis also occur commonly, particularly in travelers returning from sub-Saharan Africa or Southeast Asia. Fever and rash in the returning traveler should prompt blood cultures and serologic tests based on the exposure history. Patients with evidence of meningoencephalitis should receive lumbar puncture, blood cultures, thick/thin smears of peripheral blood, history-guided serologies, and a nape biopsy (if rabies is suspected). Jaundice in a returning traveler should be evaluated for hemolysis (for malaria), and the following tests should be performed: liver tests, thick/thin smears of peripheral blood, and directed serologic testing. Finally, patients with fever but no localizing signs or symptoms should have blood cultures performed. Routine laboratory studies usually include complete blood count with differential, electrolytes, liver tests, urinalysis, and blood cultures. Thick and thin peripheral blood smears should be done (and repeated in 12­24 hours if clinical suspicion remains high) for malaria if there has been travel to endemic areas. Other studies are directed by the results of history, physical examination, and initial laboratory tests. Bone marrow biopsy to diagnose typhoid fever could be helpful in the appropriate patient. Notes from the field: chikungunya virus spreads in the Americas- Caribbean and South America, 2013­2014. Acute and potentially life-threatening tropical diseases in western travelers-a GeoSentinel multicenter study, 1996­2011. Laboratory Findings In patients with fever and bloody diarrhea, stool culture is indicated, but in most cases, cultures are reserved for those who do not respond to antibiotics. Single-dose therapy of a fluoroquinolone usually effective if significant symptoms develop. Less common are Aeromonas, Salmonella, noncholera vibriones, E histolytica, and G lamblia. Contributory causes include unusual food and drink, change in living habits, occasional viral infections (adenoviruses or rotaviruses), and change in bowel flora. Chronic watery diarrhea may be due to amebiasis or giardiasis or, rarely, tropical sprue. The stools are usually watery and not associated with fever when caused by enterotoxigenic E coli. With invasive bacterial pathogens (Shigella, Campylobacter, Salmonella), stools can be bloody and fever may be present. If diarrhea is associated with bloody stools or persists despite a single dose of a fluoroquinolone, 1000 mg of azithromycin should be taken. In pregnant women and in areas where invasive bacteria more commonly cause diarrhea (Indian subcontinent, Asia, especially Thailand where fluoroquinolone-resistant Campylobacter is prevalent), azithromycin is the drug of choice. Because luminal concentrations are high, but tissue levels are insufficient, it should not be used in situations where there is a high likelihood of invasive disease (eg, fever, systemic toxicity, or bloody stools). Prophylaxis is started upon entry into the destination country and is continued for 1 or 2 days after leaving. For stays of more than 3 weeks, prophylaxis is not recommended because of the cost and increased toxicity. For prophylaxis, several oral antimicrobial once-daily regimens are effective, such as ciprofloxacin, 500 mg, or rifaximin, 200 mg. Bismuth subsalicylate is effective but turns the tongue and the stools black and can interfere with doxycycline absorption, which may be needed for malaria prophylaxis; it is rarely used. Packages of oral rehydration salts to treat dehydration are available over the counter in the United States (Infalyte, Pedialyte, others) and in many foreign countries. Drug Susceptibility Tests Some microorganisms are predictably inhibited by certain drugs; if such organisms are isolated, they need not be tested for drug susceptibility. Other organisms (eg, enteric gram-negative rods) are variably susceptible and generally require susceptibility testing whenever they are isolated. Organisms that once had predictable susceptibility patterns are now associated with resistance and require testing. Over the past several years, the pharmaceutical industry has shifted away from developing and producing antibacterial medications, particularly those active against gram-negative pathogens. Nonetheless, the paucity of new drugs and increasing bacterial resistance reinforce the need to use all antimicrobials judiciously. When culture and susceptibility results have been finalized, clinicians must use the most narrow-spectrum agent possible to decrease the selection pressure for antibacterial resistance. Antimicrobial drug susceptibility tests may be performed on solid media as disk diffusion tests, in broth, in tubes, in wells of microdilution plates, or as E-tests (strips with increasing concentration of antibiotic). When there appear to be marked discrepancies between susceptibility testing and clinical response, the following possibilities must be considered: 1. Failure of a poorly diffusing drug to reach the site of infection (eg, central nervous system) or to reach intracellular phagocytosed bacteria. Emergence of drug resistance in the original pathogen or superinfection with a new more resistant organism. Participation of two or more microorganisms in the infectious process, of which only one was originally detected and used for drug selection. Drugs within classes, drugs of first choice, and alternative drugs are presented in Table 30­4. Etiologic Diagnosis Based on the organ system involved, the organism causing infection can often be predicted. Laboratory Control Specimens for laboratory examination should be obtained before institution of therapy to determine susceptibility. If the specimen was obtained from a normally sterile site (eg, blood, cerebrospinal fluid, pleural fluid, joint fluid), the recovery of a microorganism in significant amounts is meaningful even if the organism recovered is different from the clinically suspected agent, and this may force a change in treatment. Suspected or Proved Etiologic Agent Drug(s) of First Choice Gram-Negative Cocci Moraxella catarrhalis Neisseria gonorrhoeae (gonococcus) Neisseria meningitidis (meningococcus) Gram-Positive Cocci es kerrs oo k eb oo e//eb /t. Gemifloxacin, levofloxacin, and moxifloxacin, the so-called respiratory fluoroquinolones, demonstrate the most reliable activity against gram-positive organisms, including penicillinresistant S pneumoniae and methicillin-sensitive S aureus. Minocycline (the most active tetracycline), and doxycycline have increased activity over tetracycline against S aureus. If a carbapenem cannot be used, either ceftazidimeavibactam or ceftolozane-tazobactam can be considered. When potentially toxic drugs (eg, aminoglycosides, flucytosine) are used, serum levels of the drug are measured to minimize toxicity and ensure appropriate dosage. In patients with altered renal or hepatic clearance of drugs, the dosage or frequency of administration must be adjusted; it is best to measure levels in older adults, in morbidly obese patients, or in those with altered kidney function when possible and adjust therapy accordingly. Thus, depending on the clinical situation, persistent fever and leukocytosis several days after initiation of therapy may not indicate improper choice of antibiotics but may be due to the natural history of the disease being treated. Duration of Antimicrobial Therapy es kerrs oo k eb oo e//eb me Generally, effective antimicrobial treatment results in reversal of the clinical and laboratory parameters of active infection and marked clinical improvement. Examples of initial antimicrobial therapy for acutely ill, hospitalized adults pending identification of causative organism. Suspected Clinical Diagnosis Likely Etiologic Diagnosis Meningitis, bacterial, community-acquired Meningitis, bacterial, age > 50, community-acquired es kerrs oo k eb oo e//eb /t. Suspected Clinical Diagnosis Likely Etiologic Agents Drugs of Choice Erysipelas, impetigo, cellulitis, ascending lymphangitis Furuncle with surrounding cellulitis es kerrs oo k eb oo e//eb /t. A respiratory fluoroquinolone5 for patients at high risk for infection due to resistant pneumococci Escherichia coli, Staphylococcus saprophyticus, Klebsiella pneumoniae, Proteus species, other gram-negative rods or enterococci E coli, K pneumoniae, Proteus species, S saprophyticus Nitrofurantoin monohydrate macrocrystals 100 mg twice daily for 5­7 days (unless pregnant); fosfomycin 3 g orally as a single dose Cephalexin, 0. For Campylobacter infection, give azithromycin, 1 g orally times one dose, or ciprofloxacin, 0. For E histolytica infection, give metronidazole, 750 mg orally three times daily for 5­10 days, followed by diiodohydroxyquinoline, 600 mg orally three times daily for 3 weeks. Use fluoroquinolones as drug of choice if recent antibiotic use within 3 months or comorbidities present. Recommendations about duration of therapy are often given based on clinical experience, not prospective controlled studies of large numbers of patients. Adverse Reactions and Toxicity es kerrs oo k eb oo e//eb me these include hypersensitivity reactions, direct toxicity, superinfection by drug-resistant microorganisms, and drug interactions. If the infection is less serious, it may be possible to stop all antimicrobials and monitor the patient closely. Food does not significantly influence the bioavailability of most oral antimicrobial agents. However, the tetracyclines (particularly tetracycline) and the quinolones chelate multivalent cations resulting in decreased oral bioavailability. Azithromycin capsules are associated with decreased bioavailability when taken with food and thus should be given 1 hour before or 2 hours after meals. A major complication of intravenous antibiotic therapy is infection due to the manipulation of the intravenous catheter. Peripheral catheters are changed every 48­72 hours to decrease the likelihood of catheter-associated infection, and antimicrobial-coated central venous catheters (minocycline and rifampin, chlorhexidine and sulfadiazine) have been associated with a decreased incidence of these infections. Most of these infections present with local signs of infection (erythema, tenderness) at the insertion site. In a patient with fever who is receiving intravenous therapy, the catheter must always be considered a potential source. Small-gauge (20­23F) peripherally inserted silicone or polyurethane catheters (Per Q Cath, A-Cath, Ven-A-Cath, and others) are associated with a low infection rate and can be maintained for 3­6 months without replacement. Skin tests using penicilloyl-polylysine and undegraded penicillin can identify most individuals with IgE-mediated reactions (hives, bronchospasm). In those patients with positive reaction to skin tests, the incidence of subsequent immediate severe reactions associated with penicillin administration is high. Only a small proportion (less than 5%) of patients with a stated history of penicillin allergy experience an adverse reaction when challenged with the drug. The decision to administer penicillin or related drugs (other beta-lactams) to patients with an allergic history depends on the severity of the reported reaction, the severity of the infection being treated, and the availability of alternative drugs. For patients with a history of severe reaction (anaphylaxis), alternative drugs should be used. In the rare situations when there is a strong indication for using penicillin (eg, syphilis in pregnancy) in allergic patients, desensitization can be performed. If the reaction is mild (nonurticarial rash), the patient may be rechallenged with penicillin or may be given another betalactam antibiotic. Allergic reactions include anaphylaxis, serum sickness (urticaria, fever, joint swelling, angioedema 7­12 days after exposure), skin rashes, fever, interstitial nephritis, eosinophilia, hemolytic anemia, other hematologic disturbances, and vasculitis. The incidence of hypersensitivity to penicillin is estimated to be 1­5% among adults in the United States. Ampicillin produces maculopapular skin rashes more frequently than other penicillins, but many ampicillin (and other beta-lactam) rashes are not allergic in origin. The nonallergic ampicillin rash usually occurs after 3­4 days of therapy, is maculopapular, is more common in patients with coexisting viral illness (especially Epstein-Barr infection), and resolves with continued therapy. Beta-lactams can induce nephritis with primary tubular lesions associated with anti-basement membrane antibodies.

Best 25 mg losartan. Best Indian Diet Plan Diabetes | Best Food to control sugar | Myths & Facts | Cure Diabetes.

Both duration of action and duration of exposure are major factors related to likelihood of withdrawal pregnancy diabetes test values cheap generic losartan canada. Common withdrawal symptoms after low to moderate daily use of benzodiazepines are classified as somatic (disturbed sleep blood sugar balance discount losartan 25 mg buy on-line, tremor diabetes insipidus in dogs prognosis cheap losartan, nausea blood sugar drops quickly discount 50 mg losartan mastercard, muscle aches) diabetes test app buy losartan online now, psychological (anxiety, poor concentration, irritability, mild depression), or perceptual (poor coordination, mild paranoia, mild confusion). Diazepam and clorazepate are the most rapidly absorbed oral benzodiazepines, which may explain the popularity of diazepam. Lorazepam does not produce active metabolites and has a half-life of 10­20 hours, characteristics useful in treating elderly patients or those with liver dysfunction. Ultra-short-acting agents such as triazolam have half-lives of 1­3 hours and may lead to rebound withdrawal anxiety. Longer-acting benzodiazepines such as flurazepam and diazepam produce active metabolites, have half-lives of 20­120 hours, and should be avoided in older adults. Since people vary widely in their response and since the medications are long lasting, the dosage must be individualized. Once this is established, an adequate and scheduled dose early in the course of symptom development will obviate the need for "pill popping," which can contribute to dependency problems. Antidepressants can themselves be anxiogenic when first started- thus, at the initiation of treatment, concomitant short-term treatment with a benzodiazepine is often indicated. Buspirone, sometimes used as an augmenting agent in the treatment of depression and compulsive behaviors, is also effective for generalized anxiety. Buspirone is usually given in a total dose of 15­60 mg/day in three divided doses. Higher doses are sometimes associated with side effects of dizziness and gastrointestinal symptoms. There is a 2- to 4-week delay before antidepressants and buspirone take effect, and patients require education regarding this lag. Gabapentin (titrated to doses of 900­1800 mg orally daily) appears effective and lacks the habit-forming potential of the benzodiazepines. Unfortunately, like buspirone, many patients find gabapentin less effective than benzodiazepines in the management of acute anxiety. Panic disorder-Antidepressants are the first-line pharmacotherapy for panic disorder. Because of initial agitation in response to antidepressants, doses should start low and be very gradually increased. High-potency benzodiazepines may be used for symptomatic treatment as the antidepressant dose is titrated upward. Both medications may produce marked withdrawal if stopped abruptly and should always be tapered. Because of chronicity of the disorders and the problem of dependency with benzodiazepine medications, it is generally desirable to use antidepressant medications as the principal pharmacologic approach. Antidepressants have been used in conjunction with beta-blockers in resistant cases. Propranolol (40­160 mg/ day orally) can mute the peripheral symptoms of anxiety without significantly affecting motor and cognitive performance. They block symptoms mediated by sympathetic stimulation (eg, palpitations, tremulousness) but not nonadrenergic symptoms (eg, diarrhea, muscle tension). Contrary to common belief, they usually do not cause depression as a side effect and can be used cautiously in patients with depression. Gabapentin, an antiseizure medication with anxiolytic properties, is an alternative to antidepressants in the treatment of social phobia in a dosage of 300­3600 mg/day, depending on response versus sedation. Specific phobias such as performance or test anxiety may respond to moderate doses of beta-blockers, such as propranolol, 20­40 mg 1 hour prior to exposure. Specific phobias tend to respond to behavioral therapies such as systematic desensitization, which is when the patient is gradually exposed to the feared object or situation in a controlled setting. These approaches share a common cognitive component of examining the thoughts associated with the fear, and behavioral technique of exposing the individual to the feared object or situation. The combination of medication and cognitivebehavioral therapy is more effective than either alone. Acceptance and commitment therapy has been used with some success in anxiety disorders. It encourages individuals to keep focused on life goals while they "accept" the presence of anxiety in their lives. Behavioral approaches are widely used in various anxiety disorders, often in conjunction with medication. Any of the behavioral techniques can be used beneficially in altering the contingencies (precipitating factors or rewards) supporting any anxiety-provoking behavior. Desensitization, by exposing the patient to graded doses of a phobic object or situation, is an effective technique and one that the patient can practice outside the therapy session. Emotive imagery, wherein the patient imagines the anxiety-provoking situation while at the same time learning to relax, helps decrease the anxiety when the patient faces the real-life situation. Social Peer support groups for panic disorder and agoraphobia have been particularly helpful. Any help in maintaining the social structure is anxiety-alleviating, and work, school, and social activities should be maintained. All can be relieved to varying degrees with medications and behavioral techniques. Patients with panic disorder are less likely to respond to cognitive-behavioral therapy if they have agoraphobia or if they think they have a low likelihood of improving with therapy. Male to female ratios are similar, with the highest rates occurring in the young, divorced, separated, and unemployed (all high-stress categories). Neurologic abnormalities of fine motor coordination and involuntary movements are common. Under extreme stress, these patients sometimes exhibit paranoid and delusional behaviors, often associated with depression, and can mimic schizophrenia. Canadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disorders. Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. A systematic review of predictors and moderators of improvement in cognitive-behavioral therapy for panic disorder and agoraphobia. Clomipramine has proved effective in doses equivalent to those used for depression. Fluoxetine has been widely used in this disorder but in doses higher than those used in depression (up to 60­80 mg orally daily). Plasma levels of clomipramine and its metabolite should be checked 2­3 weeks after a dose of 50 mg/day has been reached, with plasma levels kept under 500 ng/mL to avoid toxicity. Symptoms are excessive or persistent beyond potentially developmentally normal periods. Obsessions (recurring distressing thoughts, such as fears of exposure to germs) and compulsions (repetitive actions such as washing the hands many times, or cognitions such as counting rituals) are usually recognized by the individual as unwanted or unwarranted and are resisted, but anxiety often is alleviated only by ritualistic performance of the compulsion or by deliberate contemplation of the intruding idea or emotion. These cognitions can be identified and gradually replaced with more rational thoughts. Educating both the patient and family about the course of illness and treatment options is extremely useful in setting appropriate expectations. Vulnerability in one or more organ systems and exposure to family members with somatization problems plays a major role in the development of particular symptoms, and the "functional" versus "organic" dichotomy is a hindrance to good treatment. For example, 45% of patients describing palpitations had lifetime psychiatric diagnoses including generalized anxiety, depression, panic, and somatic symptom disorders. Similarly, 33­44% of patients who undergo coronary angiography for chest pain but have negative results have been found to have panic disorder. In any patient presenting with a condition judged to be somatic symptom disorder, depression must be considered in the diagnosis. Practice guideline for the treatment of patients with obsessivecompulsive disorder. Deep brain stimulation versus anterior capsulotomy for obsessive-compulsive disorder: a review of the literature. Conversion Disorder (Functional Neurologic Symptom Disorder) "Conversion" of psychic conflict into physical neurologic symptoms in parts of the body innervated by the sensorimotor system (eg, paralysis, aphonic) is a disorder that commonly co-occurs with panic disorder or depression. The somatic manifestation that takes the place of anxiety is often paralysis, and in some instances the dysfunction may have symbolic meaning (eg, arm paralysis in marked anger so the individual cannot use the arm to strike someone). In addition to paralysis, nonepileptic seizures are also common manifestations of a conversion disorder. Nonepileptic seizures can be difficult to differentiate from intoxication states or panic attacks and can actually occur in patients who also have epileptic seizures. Lack of postictal confusion, closed eyes during the seizure, ictal crying, and a fluctuating course can suggest nonepileptic seizures; however, some symptoms such as asynchronous movements or pelvic thrusting can occur in both nonepileptic seizures and frontal lobe seizures. Electroencephalography, particularly in a video-electroencephalography assessment unit, during the attack is the most helpful diagnostic aid in excluding epileptic seizures. A serum prolactin levels rise more than twice baseline abruptly in the postictal state is more likely to be associated with an epileptic seizure. La belle indifférence (an unconcerned affect) is not a significant identifying characteristic, as commonly believed, since individuals even with genuine medical illness may exhibit a high level of denial. It is important to identify physical disorders with unusual presentations (eg, multiple sclerosis, systemic lupus erythematosus). The somatic symptoms are associated with disproportionate and persistent thoughts about the seriousness of the symptoms, a high level of anxiety about health, or excessive time and energy are devoted to these symptoms. An empathic, realistic, optimistic approach must be maintained in the face of the expected ups and downs. Ongoing reevaluation is necessary, since somatization can coexist with a concurrent physical illness. There is a significant relationship (20%) to a lifetime history of panic-agoraphobia-depression. Preoccupation with medical and surgical therapy becomes a lifestyle that may exclude other activities. Patients most often first present to primary care clinicians and experience reassurance regarding their physical condition as only briefly helpful or dismissive. Patients complaints of symptoms should always first be carefully evaluated medically. Psychological the primary clinician can use psychological approaches when it is clear that the patient is ready to make some changes in lifestyle in order to achieve symptomatic relief. This is often best approached with orientation toward pragmatic current changes rather than an exploration of early experiences that the patient frequently fails to relate to current distress. Group therapy with other individuals who have similar problems is sometimes of value to improve coping, allow ventilation, and focus on interpersonal adjustment. If the primary clinician has been working with the patient on psychological problems related to the physical illness, the groundwork is often laid for successful psychiatric referral. For patients who have been identified as having a factitious disorder, early psychiatric consultation is indicated. One consists of a conjoint confrontation of the patient by both the primary clinician and the psychiatrist. Techniques such as biofeedback and self-hypnosis may foster recovery using this strategy. For example, the patient is told there are two possible diagnoses: (1) an organic disease that should respond to the next medical intervention (usually modest and noninvasive), or (2) factitious disorder for which the patient will need psychiatric treatment. Given these options, many patients will choose to recover and not have to admit the origin of their problem. Factitious Disorders these disorders, in which symptom production is intentional, are not somatic symptom conditions in that symptoms are produced consciously, in contrast to the unconscious process of the other somatic symptom disorders. They are characterized by self-induced or described symptoms or false physical and laboratory findings for the purpose of deceiving clinicians or other health care personnel. The deceptions may involve self-mutilation, fever, hemorrhage, hypoglycemia, seizures, and an almost endless variety of manifestations-often presented in an exaggerated and dramatic fashion (Munchausen syndrome). Factitious disorder imposed on another, previously termed "Munchausen by proxy," is diagnosed when someone (often a parent) creates an illness in another person (often a child) for perceived psychological benefit of the first person, such as sympathy or a relationship with clinicians. The duplicity may be either simple or extremely complex and difficult to recognize. The patients are frequently connected in some way with the health professions and there is no apparent external motivation other than achieving the patient role. A poor clinician-patient relationship and "doctor shopping" tend to exacerbate the problem. Medical Sedative and analgesic dependency is the most common iatrogenic complication. Patients may pursue medical or surgical treatments that induce iatrogenic problems. Thus, identifying patients with a potential somatic symptom disorder and attempting to limit tests, procedures, and medications that may lead to harm is quite important. Behavioral Behavioral therapy is probably best exemplified by biofeedback techniques. In biofeedback, the particular abnormality (eg, increased peristalsis) must be recognized and monitored by the patient and therapist (eg, by an electronic stethoscope to amplify the sounds). This is immediate feedback, and after learning to recognize it, the patient can then learn to identify any change thus produced (eg, a decrease in bowel sounds) and so become a conscious originator of the feedback instead of a passive recipient. Relief of the symptom operantly conditions the patient to utilize the maneuver that relieves symptoms (eg, relaxation causing a decrease in bowel sounds). With emphasis on this type of learning, the patient is able to identify symptoms early and initiate the countermaneuvers, thus decreasing the symptomatic problem. Migraine and tension headaches have been particularly responsive to biofeedback methods.

This level of glycemic control decreased the risk of microvascular complications (retinopathy and nephropathy) in comparison with conventional therapy (mostly diet alone) diabetes hba1c losartan 50 mg with mastercard, which achieved mean levels of HbA1c of 7 diabetes symptoms negative test 50 mg losartan order overnight delivery. Weight gain occurred in intensively treated patients except when metformin was used as monotherapy blood sugar 78 buy discount losartan 50 mg on-line. No adverse cardiovascular outcomes were noted regardless of the therapeutic agent diabetes type 2 weight cheap generic losartan uk. In the overweight or obese subgroup diabetes youth services discount losartan 50 mg without prescription, metformin therapy was more beneficial than diet alone in reducing the number of cases that progressed to diabetes as well as decreasing the number of patients who suffered myocardial infarctions and strokes. Hypoglycemic reactions occurred in the intensive treatment groups, but only one death from hypoglycemia was documented during 27,000 patient-years of intensive therapy. The Diabetes Control and Complications Trial, a long-term therapeutic study involving 1441 patients with type 1 diabetes mellitus, reported that "near" normalization of blood glucose resulted in a delay in the onset and a major slowing of the progression of established microvascular and neuropathic complications of diabetes during a follow-up period of up to 10 years. Multiple insulin injections (66%) or insulin pumps (34%) were used in the intensively treated group, who were trained to modify their therapy in response to frequent glucose monitoring. The conventionally treated groups used no more than two insulin injections, and clinical well-being was the goal with no attempt to modify management based on HbA1c determinations or the glucose results. Over the study period, which averaged 7 years, there was an approximately 60% reduction in risk between the two groups in regard to diabetic retinopathy, nephropathy, and neuropathy. Intensively treated patients had a threefold greater risk of serious hypoglycemia as well as a greater tendency toward weight gain. Even though the between-group differences in mean HbA1c narrowed over 4 years, the group assigned » Clinical Trials in Diabetes s errs ook e ook e/eb e/eb /t. In those patients with obesity and type 2 diabetes, weight reduction by caloric restriction is an important goal of the diet (see Chapter 29). Patients with type 1 diabetes or type 2 diabetes who take insulin should be taught "carbohydrate counting," so they can administer their insulin bolus for each meal based on its carbohydrate content. The current recommendations for saturated fats and dietary cholesterol intake for people with diabetes are the same as for the general population. Saturated fats should be limited to less than 10% of daily calories and dietary cholesterol intake should be less than 300 mg/day. For those patients with kidney disease, dietary protein should be maintained at the recommended daily allowance of 0. In fact, reducing blood pressure by this amount had substantially greater impact on microvascular outcomes than that achieved by lowering HbA1c from 7. Use of a calcium channel blocker added to both treatment groups appeared to be safe over the long term in this diabetic population despite some controversy in the literature about its safety in patients with diabetes. The intensively treated group had significantly reduced risk of myocardial infarction (15%, P = 0. The subgroup of overweight or obese subjects who were initially randomized to metformin therapy showed sustained reduction in risk of myocardial infarction and death from any cause in the follow-up period. Unlike the sustained benefits seen with glucose control, there were no sustained benefits from having been in the more tightly controlled blood pressure group. Both blood pressure groups were at similar risk for microvascular events and diabetes-related end points during the follow-up period. Blood pressure benefits, however, last only as long as the blood pressure is well controlled. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulindependent diabetes mellitus. Dietary fiber-Plant components such as cellulose, gum, and pectin are indigestible by humans and are termed dietary "fiber. In contrast, soluble fibers such as gums and pectins, as found in beans, oatmeal, or apple skin, tend to retard nutrient absorption rates so that glucose absorption is slower and hyperglycemia may be slightly diminished. High soluble fiber content in the diet may also have a favorable effect on blood cholesterol levels. There is no specific recommendation on the percentage of calories that should come from carbohydrate, protein, and fat. In general, most es kerrs oo k eb oo e//eb me Eating low glycemic index foods results in lower glucose levels after meals. High glycemic index foods have values of 70 or greater and include baked potato, white bread, and white rice. Glycemic index is lowered by presence of fats and protein when food is consumed in a mixed meal. Even though it may not be possible to accurately predict the glycemic index of a particular food in the context of a meal, it is reasonable to choose foods with low glycemic index. Artificial and other sweeteners-Saccharin (Sweet N Low), sucralose (Splenda), acesulfame potassium (Sweet One), and rebiana (Truvia) are "artificial" sweeteners that can be used in cooking and baking. Fructose represents a "natural" sugar substance that is a highly effective sweetener, induces only slight increases in plasma glucose levels, and does not require insulin for its metabolism. This does not preclude, however, ingestion of fructose-containing fruits and vegetables or fructose-sweetened foods in moderation. Sugar alcohols, also known as polyols or polyalcohol, are commonly used as sweeteners and bulking agents. They occur naturally in a variety of fruits and vegetables but are also commercially made from sucrose, glucose, and starch. They are not as easily absorbed as sugar, so they do not raise blood glucose levels as much. Therefore, sugar alcohols are often used in food products that are labeled as "sugar free," such as chewing gum, lozenges, hard candy, and sugar-free ice cream. However, if consumed in large quantities, they will raise blood glucose and can cause bloating and diarrhea. Tolbutamide is probably best administered in divided doses (eg, 500 mg before each meal and at bedtime); however, some patients require only one or two tablets daily with a maximum dose of 3000 mg/day. Because of its short duration of action, which is independent of kidney function, tolbutamide is relatively safe to use in kidney disease. Prolonged hypoglycemia has been reported rarely with tolbutamide, mostly in patients receiving certain antibacterial sulfonamides (sulfisoxazole), phenylbutazone for arthralgias, or the oral azole antifungal medications to treat candidiasis. These medications apparently compete with tolbutamide for oxidative enzyme systems in the liver, resulting in maintenance of high levels of unmetabolized, active sulfonylurea in the circulation. Chlorpropamide has a prolonged biologic effect, and severe hypoglycemia can occur especially in older adults as their renal clearance declines with aging. Its other side effects include alcohol-induced flushing and hyponatremia due to its effect on vasopressin secretion and action. These medications should be used with caution in patients with cardiovascular disease or in elderly patients, in whom prolonged hypoglycemia would be especially dangerous. Some reports suggest that 10 mg is a maximum daily therapeutic dose, with 15­20 mg having no additional benefit in poor responders and doses over 20 mg actually worsening hyperglycemia. A "Press Tab" formulation of "micronized" glyburide-easy to divide in half with slight pressure if necessary-is available. Glyburide is metabolized in the liver into products with hypoglycemic activity, which probably explains why assays specific for the unmetabolized compound suggest a plasma half-life of only 1­2 hours, yet the biologic effects of glyburide are clearly persistent 24 hours after a single morning dose in diabetic patients. Glyburide is unique among sulfonylureas in that it not only binds to the pancreatic B cell membrane sulfonylurea receptor but also becomes sequestered within the B cell. This may also contribute to its prolonged biologic effect despite its relatively short circulating half-life. Glyburide has few adverse effects other than its potential for causing hypoglycemia, which at times can be prolonged. Medications for Treating Hyperglycemia errs es ook b ook b the medications for treating type 2 diabetes are listed in Table 27­4. Sulfonylureas-The primary mechanism of action of the sulfonylureas is to stimulate insulin release from pancreatic B cells. Sulfonylureas are used in patients with type 2 but not type 1 diabetes, since these medications require functioning pancreatic B cells to produce their effect on blood glucose. Sulfonylureas are metabolized by the liver and apart from acetohexamide, whose metabolite is more active than the parent compound, the metabolites of all the other sulfonylureas are weakly active or inactive. The metabolites are excreted by the kidney and, in the case of the secondgeneration sulfonylureas, partly excreted in the bile. Tablet Size Acetohexamide (Dymelor) Chlorpropamide (Diabinese) Gliclazide (not available in United States) Glimepiride (Amaryl) es kerrs oo k eb oo e//eb /t. Symlin pen day (20 units on U100 insulin syringe) if no nau60 or Symlin pen 120 sea for 3­7 days. It does not cause water retention, as chlorpropamide does, but rather slightly enhances free water clearance. Glyburide should not be used in patients with liver failure and chronic kidney disease because of the risk of hypoglycemia. Elderly patients are at particular risk for hypoglycemia even with relatively small daily doses. When higher daily doses are required, they should be divided and given before meals. Like repaglinide, it causes a brief rapid pulse of insulin, and when given before a meal it reduces the postprandial rise in blood glucose. For most patients, the recommended starting and maintenance dose is 120 mg three times a day before meals. Like the other insulin secretagogues, its main side effects are hypoglycemia and weight gain. For maximum effect in reducing postprandial hyperglycemia, glipizide should be ingested 30 minutes before meals, since rapid absorption is delayed when the medication is taken with food. At least 90% of glipizide is metabolized in the liver to inactive products, and 10% is excreted unchanged in the urine. Because of its lower potency and shorter duration of action, it is preferable to glyburide in elderly patients and for those patients with kidney disease. However, this formulation appears to have sacrificed its lower propensity for severe hypoglycemia compared with longer-acting glyburide without showing any demonstrable therapeutic advantages over glyburide. Gliclazide (not available in the United States) is another intermediate duration sulfonylurea with a duration of action of about 12 hours. The medication is metabolized by the liver; the metabolites and conjugates have no hypoglycemic effect. Glimepiride has a long duration of effect with a halflife of 5 hours allowing once or twice daily dosing. Glimepiride achieves blood glucose lowering with the lowest dose of any sulfonylurea compound. A single daily dose of 1 mg/day has been shown to be effective, and the maximal recommended dose is 8 mg. It is completely metabolized by the liver to relatively inactive metabolic products. It can be used alone or in conjunction with other oral agents or insulin in the treatment of patients with type 2 diabetes. A side benefit of metformin therapy is its tendency to improve both fasting and postprandial hyperglycemia and hypertriglyceridemia in obese patients with diabetes without the weight gain associated with insulin or sulfonylurea therapy. Patients with chronic kidney disease should not be given this medication because failure to excrete it would produce high blood and tissue levels of metformin that could stimulate lactic acid overproduction. In the United States, metformin use is not recommended at or above a serum creatinine level of 1. In the United Kingdom, the recommendations are to review metformin use when the serum creatinine exceeds 130 mcmol/L (1. Patients with liver failure or persons with excessive alcohol intake should not receive this medication-lactic acid production from the gut and other tissues, which rises during metformin therapy, could result in lactic acidosis when defective hepatocytes cannot remove the lactate or when alcohol-induced reduction of nucleotides interferes with lactate clearance. The maximum dosage of metformin is 2550 mg, although little benefit is seen above a total dose of 2000 mg. It is important to begin with a low dose and increase the dosage very gradually in divided doses-taken with meals-to reduce minor gastrointestinal upsets. A common schedule would be one 500-mg tablet three times a day with meals or one 850- or 1000-mg tablet twice daily at breakfast and dinner. Meglitinide analogs-Repaglinide is structurally similar to glyburide but lacks the sulfonic acid-urea moiety. It is rapidly absorbed from the intestine and then undergoes complete metabolism in the liver to inactive biliary products, giving it a plasma half-life of less than 1 hour. Metabolism is by cytochrome P450 3A4 isoenzyme, and other medications that induce or inhibit this isoenzyme may increase or inhibit (respectively) the metabolism of repaglinide. The medication may be useful in patients with kidney impairment or in older adults. Mitiglinide is a benzylsuccinic acid derivative that binds to the sulfonylurea receptor and is similar to repaglinide in its clinical effects. These effects are dose-related, tend to occur at onset of therapy, and often are transient. However, in 3­5% of patients, therapy may have to be discontinued because of persistent diarrheal discomfort. Patients switching from immediate-release metformin to comparable dose of extended-release metformin may experience fewer gastrointestinal side effects. Hypoglycemia does not occur with therapeutic doses of metformin, which permits its description as a "euglycemic" or "antihyperglycemic" medication rather than an oral hypoglycemic agent. Metformin interferes with the calcium dependent absorption of vitamin B12-intrinsic complex in the terminal ileum; vitamin B12 deficiency can occur after many years of metformin use. Periodic screening with vitamin B12 levels should be considered, especially in patients with peripheral neuropathy or if a macrocytic anemia develops. Increased intake of dietary calcium may prevent the metformininduced B12 malaborption. Lactic acidosis has been reported as a side effect but is uncommon with metformin in contrast to phenformin. Almost all reported cases have involved persons with associated risk factors that should have contraindicated its use (kidney, liver, or cardiorespiratory insufficiency; alcoholism; advanced age). Acute kidney injury can occur rarely in certain patients receiving radiocontrast agents. Metformin therapy should therefore be temporarily halted on the day of radiocontrast administration and restarted a day or two later after confirmation that kidney function has not deteriorated.

References

• Schroth MK, Grimm E, Frindt P, et al. Rhinovirus replication causes RANTES production in primary bronchial epithelial cells. Am J Respir Cell Mol Biol 1999; 20: 1220-1228.
• Hunt SA, Abraham WT, Chin MH, et al. 2009 focused update incorporated into the ACC/AHA 2005 guidelines for the diagnosis and management of heart failure in adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119(14):e391-e479.
• Frykberg ER, Crump JM, Vines FS, et al. A reassessment of the role of arteriography in penetrating proximity extremity trauma: a prospective study. J Trauma. 1989;29(8):1041-1050; discussion 1050-1052.
• Sung PH, Chang CL, Tsai TH, et al. Apoptotic adipose-derived mesenchymal stem cell therapy protects against lung and kidney injury in sepsis syndrome caused by cecal ligation puncture in rats. Stem Cell Res Ther. 2013;4:155.
• Burns KE, Adhikari NK, Meade MO: Noninvasive positive pressure ventilation as a weaning strategy for intubated adults with respiratory failure. Cochrane Database Syst Rev (4):CD004127, 2003.